The University of Michigan Department of Pathology is comprised of nearly 200 faculty and 1,100 staff, who provide the best patient care and research possible.
Congratulations to #UMichPath researchers, Drs. Jolanta Grembecka and Tomasz Cierpicki on their recent @US_FDA approval of the first once-daily oral therapy for relapsed/refractory NPM1-mutant acute myeloid leukemia.
“This transformative discovery, grounded in research conducted in the Department of Pathology, marks an important moment for our community. The work of Drs. Grembecka and Cierpicki, now recognized through FDA approval, reflect the strength of our scientific environment and our commitment to improving care for patients. It is meaningful to see U-M Pathology contribute to a therapy that is making a real difference for those with leukemia,” said Charles Parkos, Chair of the Department of Pathology.
Read about their work: michmed.org/qNYd4
ALT Tomasz Cierpicki, left, and Jolanta Grembecka, both professors of pathology, recently received FDA approval for a drug intended for patients with acute myeloid leukemia and an NPM1 genetic mutation. (Leisa Thompson, Michigan Photography).
Dr. Sara Varadarajan has recently begun her independent research program, which is supported by her @NIHFunding K99/R00 Award, supporting groundbreaking research in inflammation, tissue repair, and mucosal wound healing. Read her story: michmed.org/W382k
A new global partnership between U-M Pathology, @UM_cghe, and @AKUHNairobi is helping shape the future of pathology. By combining digital pathology, AI, and international collaboration, researchers are working to reduce the time to diagnosis of colorectal cancer in Kenya from weeks to days. michmed.org/GYn3x
ALT A colorful digital pathology laboratory features microscopes, computer screens displaying tissue samples and pathogens, specimen tubes, and laboratory professionals using advanced technology. The artwork symbolizes the integration of digital pathology, artificial intelligence, and global collaboration to improve cancer diagnosis and patient care in low-resource settings.
Credit: Illustration for “The Path(ology) Forward” by Tara Roberts, Medicine at Michigan, Michigan Medicine.
Congratulations to Chang Kim, PhD, on his appointment as Faculty Director of the Flow Cytometry Core in the Biomedical Research Core Facilities! A professor of pathology and a nationally recognized leader in flow cytometry, Dr. Kim brings decades of expertise to support strategic planning, technology development, instrumentation funding, and service expansion for the research community @umichmedicine.
Read More: michmed.org/72jJr
After 35 years at #UMichPath, Yinru Sieracki is retiring and leaving behind a legacy of excellence and dedication to patient care. From work in electron microscopy to mentoring generations, her impact will be felt for years to come. Wishing Yinru a wonderful retirement filled with travel, art, and new adventures!
Read her story: michmed.org/XGrXX
This weekend, future healthcare leaders got a firsthand look at the many career paths within medicine during @umichmedicine’s Youth Summit at the Big House. #UMichPath was proud to participate and share how pathology plays a vital role in patient care, research and innovation.
Driven by a passion for organic chemistry and advancing translational drug discovery, Dr. Amol Mhetre’s scientific journey spans the globe. Please join us in welcoming our newest faculty member to #UMichPath! michmed.org/5K87r
The human body has lessons to teach all of us in medicine. As a hematopathologist, I’m especially partial to the bone marrow. During my 2026 commencement keynote at Loyola University Chicago Stritch School of Medicine, I shared how the marrow models attentiveness, responsiveness, connectedness, adaptability, and resilience in ways that medicine should never forget.
Here’s a snapshot of a few of those lessons.
@LoyolaStritch@UMichPath@umichmedicine@UMichRISE@UMichMedSchool